A worrying number of patients with an initially mild infection of Covid are developing long term conditions and symptoms that require medical attention. CDC suggest up 68 percent of us.
Today we explore the remarkable drug Paxlovid before turning to a new report suggesting we were wrong. The drug now appears not associated with a higher probability of COVID-19 re-infection.